Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...
A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in ...
News Medical on MSN
Johns Hopkins Scientists Develop Targeted Therapy for T-Cell Lymphomas and Leukemias
Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that ...
On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...
New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.
As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...
Saved from precursor B-cell acute lymphoblastic leukemia, the Nobel Prize winning CAR T-cell therapy gave Bryn Ailinger a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results